RNA – avidity biosciences, inc. (US:NASDAQ)
Stock Stats
News
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Avidity Biosciences (NASDAQ:RNA) was given a new $72.00 price target on by analysts at Evercore ISI.
Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge [Yahoo! Finance]
Form DFAN14A Avidity Biosciences, Filed by: NOVARTIS AG
Form DFAN14A Avidity Biosciences, Filed by: NOVARTIS AG
Form DEFA14A Avidity Biosciences,
Form 4 Avidity Biosciences, For: Jan 07 Filed by: Moriarty John B
Form 4 Avidity Biosciences, For: Jan 07 Filed by: MacLean Michael F
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.